CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falk, R. T.
Right arrow Articles by Ziegler, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falk, R. T.
Right arrow Articles by Ziegler, R. G.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 221-226, January 2005
© 2005 American Association for Cancer Research

Urinary Estrogen Metabolites and Their Ratio among Asian American Women

Roni T. Falk1, Thomas R. Fears1, Xia Xu1, Robert N. Hoover1, Malcolm C. Pike2, Anna H. Wu2, Abraham M.Y. Nomura3, Laurence N. Kolonel3, Dee W. West4, Daniel W. Sepkovic5, H. Leon Bradlow5 and Regina G. Ziegler1

1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 2 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; 3 Etiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii; 4 Northern California Cancer Center, Union City, California; and 5 Alice and David Jurist Institute for Research, Hackensack University Medical Center, Hackensack, New Jersey

Requests for reprints: Roni T. Falk, Environmental Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, MSC-7234, Suite 7070, Bethesda, MD 20892. Phone: 301-435-3982. E-mail: falkr{at}exchange.nih.gov

Controversy persists regarding the role of a low ratio of 2-hydroxyestone (2-OHE1)/16{alpha}-hydroxyestrone (16{alpha}-OHE1) as a potential estrogen metabolism marker of increased risk for breast cancer. Most of the evidence has been provided by case-control studies, where tumor effects on hormone metabolism are not known. Studies in populations at various risk of breast cancer are not consistent, with some suggesting that levels of the ratio may be altered by changes in diet and exercise. We studied Asian American women participating as controls in a case-control study of breast cancer in which migration history—a composite of the subject's place of birth, type of residence in Asia (urban or rural), length of time living in the West, and grandparents' place of birth—was associated with a 6-fold risk gradient that paralleled the historical differences in incidence rates between the United States and Asian countries. This population offered the possibility to address whether the ratio of 2-OHE1:16{alpha}-OHE1 differs according to recognized breast cancer risk factors, including migration history. Overnight 12-hour urines were obtained from 368 premenopausal and 143 naturally postmenopausal women of Chinese, Japanese, or Filipino descent who donated urines between 1985 and 1988. The estrogen metabolites 2-OHE1 and 16{alpha}-OHE1 were measured with an ELISA kit and adjusted for creatinine levels. In each ethnic group, the ratio of 2-OHE1:16{alpha}-OHE1 was consistently lower in women born in the West than in those who had migrated from Asia. For premenopausal women, the ratio declined 20% due to lower levels of 2-OHE1. Among postmenopausal women, the ratio was 23% lower in those born in the West, but no consistent patterns based on place of birth were observed for either 2-OHE1 or 16{alpha}-OHE1. The ratio did not vary with most recognized breast cancer risk factors, except for lower metabolite ratios in women with a younger age at first birth and more children, which runs contrary to the hypothesis, because both characteristics reduce breast cancer risk. Our study suggests that the ratio of 2-OHE1:16{alpha}-OHE1 may be a marker for lifestyle influences on estrogen metabolism associated with westernization.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, N. Potischman, and R. N. Hoover
Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W.-H. Wu, Y.-P. Kang, N.-H. Wang, H.-J. Jou, and T.-A. Wang
Sesame Ingestion Affects Sex Hormones, Antioxidant Status, and Blood Lipids in Postmenopausal Women
J. Nutr., May 1, 2006; 136(5): 1270 - 1275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.